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Abstract The incidence and severity of endometriosis in ad-
olescent are comparable with the incidence in adult women.
The mean delay between the onset of symptoms and the final
diagnosis varies between 6.4 and 11.7 years. The longer the
diagnosis is delayed, the more the endometriosis can progress
to a more severe stage certainly in the group of patients with
pelvic pain. The evolution of endometriosis and its progres-
sivity are not predictable, and the severity of the disease is not
directly related to the degree of pain. Endometriotic cysts have
a detrimental effect on the ovarian reserve by the evolution in
time and the surgical excision technique. Already, in small
endometriotic cysts (<4 cm), loss of follicular reserve is pres-
ent together with the formation of fibrosis in the cortex of the
ovary. Early diagnosis of endometriosis in the adolescent de-
serves our full attention. Non-invasive imaging techniques
like 2-D and 3-D ultrasound are helpful in the early diagnosis.
Early ablative surgery is recommendable. Although laparos-
copy is traditionally recommended, transvaginal laparoscopy
has been shown to be most effective in ablating
endometriomas with a maximum diameter of 3 cm. Early
detection and intervention will contribute to a better quality
of life in these adolescents and also to a lower damage of the
ovarian tissue by a less invasive ablative surgery.
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Introduction
Ovarian endometriosis, a disease similar to the Mona Lisa
face, fails to be grasped and identified by current descriptions.
At present, the diagnosis requires an invasive surgical tech-
nique, whether laparotomy or laparoscopy, to diagnose the
presence of ectopic endometrium-like tissue. In the young
woman, the symptoms may be suggestive, but vary greatly
and elicit frequent compassion rather than investigation and
treatment. Nevertheless, understanding endometriosis in the
young woman may shed light on the more complex appear-
ance in the adult woman and improve early-stagemanagement
[1]. This review will address the recent literature regarding
premenarchal and adolescent endometriosis and discuss in
particular the inherent risks of the delay in diagnosis and man-
agement of ovarian involvement.
Premenarchal and adolescent endometriosis
Endometriosis is described as premenarchal and distinguished
from adolescent when symptoms and lesions occur during the
phase of telarche before the menarche.
Premenarchal endometriosis
Marsh and Laufer [2] identified, in 2005, endometriosis as a
cause of chronic pelvic pain in five premenarchal girls without
an obstructive anomaly of the reproductive tract. Breast de-
velopment in the patients ranged from Tanner I to Tanner III,
and non-gynecological etiologies for pelvic pain were exclud-
ed. All subjects had laparoscopy with the identification of
multiple clear and red lesions consistent with stromal endo-
metriosis. Postoperatively, all of the girls had marked im-
provement of their pelvic pain based on self-reported pain
scales. Two of the subjects had subsequent repeat
S. Gordts (*) : P. Puttemans : S. Gordts : I. Brosens
Leuven Institute for Fertility & Embryology, Tiensevest 168,
3000 Leuven, Belgium
e-mail: Stephan.gordts@lifeleuven.be
Gynecol Surg (2015) 12:21–30
DOI 10.1007/s10397-014-0877-x
laparoscopies 6 and 8 years after their initial surgery, which
revealed classical endometriosis. More cases of endometriosis
occurring before or around the time of menarche have been
documented. Gogacz et al. [3] described an 11-year-old pa-
tient with a left ovarian endometrioma. Her menarche oc-
curred spontaneously 6 months after surgery. Ebert et al. [4]
reported on a 9-year-old premenarchal girl with cyclic pelvic
pain since her 8th year of life. Multiple clear, red, and
vascularized flame-like peritoneal lesions were observed.
The resected lesions showed cytogenic stroma, small glands,
and pigment-carrying macrophages.
Adolescent endometriosis
Originally described more than a century ago, endometriosis
is thought of as a disease that affects adult women, but there is
increasing awareness of its presence in young women. The
disorder represents already in the young woman a vague and
perplexing entity that frequently results in chronic pelvic pain,
adhesive disease, and infertility. Differences exist between
adolescent and adult types of endometriosis, but it is likely
that diagnosis and treatment during adolescence decrease dis-
ease progression and prevent subsequent reproductive failure.
The first study of adolescent endometriosis by Hanton et al.
[5] covered the Mayo Clinic experience from 1935 until 1964
and included 68 young patients. The authors tried to determine
the frequency, relation to menarche, and outcome. Sixty-three
(93 %) out of the 68 patients experienced menarche 5 to
10 years before diagnosis, 9 could not date menarche but were
21 or younger at diagnosis, and 6 had congenital obstruction
to menstrual flow. Usually, patients complained of dysmenor-
rhea or other pelvic pain, but 11 (16 %) had no pelvic com-
plaints. Only three complained chiefly of infertility. Ten pa-
tients initially had procedures ablating menstrual function and
58 had conservative operations. One month to 25 years after
conservative treatment, 15 patients required subsequent oper-
ation, radical in 12 cases. Subsequent fertility was about 50 %
in this study. Parker and collaborators [6] recently investigated
menstrual pain and other symptoms in teenagers to evaluate
how many experience a degree of menstrual disturbance that
needs to be further investigated. In a population of 1051 girls
aged between 15 and 19 years, the authors concluded that
menstrual pain and symptoms are common in teenagers. Girls
indicating moderate to severe pain in association with a high
number of menstrual symptoms, school absence, and interfer-
ence with life activities should be effectively managed to min-
imize menstrual morbidity. Those girls who do not respond to
medical management should be considered for further inves-
tigation for possible underlying pathology, such as endome-
triosis. In a study of Laufer et al. [7, 8], the prevalence of
endometriosis in adolescents with chronic pelvic pain not
responding to medical therapy was 69.6 %.
A recent Chinese study by Yang et al. [9] included 63
patients less than 20 years old with surgically diagnosed en-
dometriosis at the Peking Union Medical College Hospital
from 1992 to 2010. Mean age at diagnosis was 18.41±
1.84 years with a much earlier disease onset in adolescents
with genital tract malformations. Of the 35 patients with
follow-up time that ranged from 12 to 98 months, 9 in 15
patients discontinued medical treatment after operation and
had a recurrence. Seven in 15 patients who took oral contra-
ceptive pills or progestin only pills had recurrence, but none of
the five patients receiving gonadotropin-releasing hormone
agonist. Among the 15 cases without postoperative medical
therapy, all five cases with lesions at multiple sites had recur-
rence, while only four of the other ten cases had relapse. The
difference was of statistical significance (Fisher’s exact test,
P=0.044). The authors concluded that the presence of lesions
at multiple sites is a risk factor of recurrence and that GnRHa
can effectively prevent the recurrence.
Recent studies of endometriosis in adolescents show clear-
ly that the disease is no longer characterized by subtle super-
ficial lesions, but also by the presence of ovarian adhesions
and endometriomas [1]. Comparison of the clinical features of
the endometrioma in adolescent women to women of other
age groups by Lee et al. [10] showed that adolescent females
experienced menarche at a significantly earlier age and that
the main symptom was pain (77 %). The proportion of inci-
dental detection (23 %) was low in comparison with women
older than 30 years. The authors concluded that, apart from
pain, there were no other differences between the age groups.
Apparently, adolescent endometriosis is a hidden, debilitating,
and progressive disease that deserves greater attention for di-
agnosis and more appropriate management for the preserva-
tion of the integrity of reproductive life.
Views on the pathogenesis of premenarchal endometriosis
The presence of peritoneal and ovarian endometriosis in
premenarchal girls without an obstructive anomaly has sup-
ported the concept that endometriosis may result from an eti-
ology other than retrograde menses as proposed by Sampson
in 1927 [11]. Batt and Mitwally [12] have argued for recog-
nition of embryonic Mullerian rests as the pathogenesis in
cases of early endometriosis not explained by accepted theo-
ries. Along with John Huffman, a founder of the subspecialty
of pediatric and adolescent gynecology in North America,
they proposed that telarche be recognized as a developmental
benchmark, after which endometriosis is included in the dif-
ferential diagnosis of chronic pelvic pain. In recent years,
Signorile et al. [13, 14] demonstrated the presence of ectopic
endometrium in human female fetuses at different gestational
ages. They suggested that endometriosis is caused by
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dislocation of primitive endometrial tissue outside the uterine
cavity during organogenesis. Also, Bouquet de Jolinière et al.
[15] described the presence of misplaced endometrial glands
and embryonic duct remnants in six of seven fetuses referring
to the possible theory of involvement ofMüllerian orWolffian
cell rests in the pathogenesis of endometriosis.
Following the current available evidence regarding stem/
progenitor cells in the human endometrium, Oliveira et al.
[16] suggested the possible involvement of these cells in the
etiology of endometriosis. The identification of stem cells in
animal and human tissues is, however, very complex, and the
putative stem cells are supposed to be found through several
assays such as clonogenicity, label-retaining cells, “side pop-
ulation” cells, undifferentiating markers, and cellular differen-
tiation. Bone marrow-derived stem cells transplanted into
humans and animals have also been identified in eutopic en-
dometrium and endometriotic implants. The actual scientific
knowledge obtained on the existence of somatic stem cells in
the murine and human endometrium and the implication and
biological pathways of these cells in endometriosis has been
recently reviewed by Cervello et al. [17]. Recently, Brosens
and Benagiano [18] formulated the hypothesis that perinatal
uterine bleeding occurring in some newborns—a phenome-
non that is routinely discounted as insignificant—may be a
cause of premenarchal and adolescent endometriosis. The hy-
pothesis is based on anatomical and functional observations.
First, in the perinatal period, the fetal endometrium shows
decidualization, shedding, and bleeding in some 5 % of the
newborn girls [19, 20]. Secondly, the anatomical structure of
the neonatal uterus favors, in contrast with menstrual bleed-
ing, tubal reflux [21]. Thirdly, in premenarchal endometriosis,
the sites of implantations have a similar pelvic pattern as in
adolescent and adult endometriosis [2]. Fourthly, Arcellana
has documented a case of neonatal endometriosis in 1996
[22]. Finally, neonatal and premenarchal lesions with scanty
glandular development seem to reflect a stromal endometri-
osis that later develops into an adolescent and adult type of
endometriosis. For these reasons, there is no reason to postu-
late a different origin and pathogenesis for premenarchal, ad-
olescent, and adult endometriosis. Sampson’s hypothesis can
be modified by assuming the perinatal bleeding as the first
uterine bleeding with reflux with the shedding of predomi-
nantly endometrial stem/niche cells [23].
Progression of endometriosis
Progression of the endometriotic lesion is characterized by
two stages of morphological activities. In the first phase, the
superficial endometriotic implant responds like eutopic endo-
metrium to ovarian steroid hormones resulting in prolifera-
tion, secretory changes, and decidualization followed by su-
perficial desquamation and bleeding. In the later phase, the
interstitial implant is associated with smooth muscle metapla-
sia and formation of deep or adenomyotic nodules. In the
ovary, progression of endometriosis leads to bleeding and ad-
hesions resulting in endometrioma formation, while interstitial
smooth muscle metaplasia and fibrosis affect the cortical zone
and decrease the follicular reserve.
Ovarian endometrioma formation
Superficial endometriosis is characterized by adhesion forma-
tion. It is now well accepted that the typical ovarian
endometrioma is caused by encapsulation of endometrial tis-
sue between the ovarian cortex and the posterior leaf or the
parametrium as originally described by Hughesdon in 1957
[24]. In an initial stage, Gordts et al. described the presence of
small adhesions only upon the ovarian surface covering the
early formation of an invaginating small endometrioma iden-
tified as a brownish vesicle [25].
Careful inspection by ovarioscopy [26, 27] allows identifi-
cation of vascularization and pigmentation of the pseudocyst
lining and to distinguish between the endometrioma with a
pearl white or yellowish-pigmented cortex lined by a thin
mucosa with prominent neoangiogenesis (red endometrioma)
and the endometrioma with a dark, pigmented fibrotic tissue
(black endometrioma). Occasionally, the endometrioma is
connected to a corpus luteum that has a completely different
surface, and early colonization by endometriotic surface epi-
thelium can be observed. One can argue that full excision of
the red endometrioma represents, in many cases, excessive
surgery and that particularly in young adults, in whom fibrosis
is absent, this invariably results in the resection of healthy
ovarian cortex.
Cortical and interstitial changes in the endometriotic cyst
One of the subtle and poorly appreciated changes associated
with ectopic endometrium is smooth muscle metaplasia
(SMM). According to Anaf et al. [28], deep infiltrating endo-
metriosis (deeper than 5 mm under the peritoneum) in adults
often takes the form of a nodular lesion (or “adenomyotic
nodule”) consisting of smooth muscles and fibrosis with ac-
tive glands and scanty stroma. They studied in adults 54
endometriotic lesions originating from four different pelvic
locations (peritoneum, ovary, rectovaginal septum, and
uterosacral ligaments) using a monoclonal antibody against
muscle-specific actin for identifying the presence of smooth
muscles and quantifying the smooth muscle content. They
found that smooth muscles were frequent components of
endometriotic lesions in pelvic locations and concluded that,
in adults, the definition of distinct endometriotic entities based
on the difference in the tissue composition of the lesions
(endometriotic nodules versus adenomyotic nodules) is incon-
sistent with the very frequent presence of smooth muscle cells
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in endometriosis irrespective of their localization. In a study of
ovarian endometriomas, Fukunaga [20] noted that SMM in
ovarian endometriosis is not an uncommon phenomenon
and assumed that smooth muscle may originate from either
metaplastic endometrial stromal cells in endometriotic foci or
metaplastic ovarian stromal cells in the rim of endometriosis.
At present, Sampson [11] and Hughesdon [24] are the only
investigators to study systematically histological sections of
ovaries with endometrioma in situ. Admittedly, the specimens
were obtained in older women and, therefore, represent a later
stage of the disease. The pathologist Hughesdon described the
main features of disruption and disorganization of the cortical
wall and loss of identity of the inner cortex by smooth muscle
cell metaplasia occurring in any of its layer in 86 % of the
chocolate cysts. As a result, the inner cortexmay become quite
unrecognizable by stretching and muscular metaplasia, and in
addition, there is no cleavage plane. It is therefore likely that
the main risk of late diagnosis and treatment of the ovarian
endometrioma is the progressive structural disorganization of
the inner cortex. In the absence of a cleavage plane, surgical
reconstruction of the ovary is becoming critically difficult.
The changes are not dependent on the size of the pseudocyst.
In a study of cystectomy specimens, Scurry et al. [29] noted
that the presence of oocyte in such specimens is influenced, in
addition to age, by fibrosis, SMM, and stretching of the cortex
making identification frequently unrecognizable. Clement
[30] noted that a biopsy is required for histological diagnosis,
but the diagnostic value is compounded by tissue that is lim-
ited to a small biopsy specimen.
Loss of follicle reserve
The question arises to which extent the SMM associated with
the ovarian endometrioma affects the follicular reserve. In a
recent study, Kuroda at al. [31] obtained a small amount of
normal ovarian tissue during ovarian cystectomy in 61women
with ovarian endometrioma and 42 patients with non-
endometriotic cysts. The density of follicles in the ovarian
tissues correlated with the age of the patients in both groups,
but in women aged <35 years, the relative density of follicles
in healthy ovarian tissues was consistently lower in the
endometriotic cyst group compared to the non-endometriotic
cyst group. The resection rate of normal ovarian tissue in
cystectomy specimen of the endometriosis group was signif-
icantly higher than in the non-endometriotic cyst group. The
authors concluded that ovarian endometriomas have a detri-
mental impact on follicle reserve in younger patients, and
furthermore, that laparoscopic cystectomy for endometriomas
may accelerate the rate of oocytes loss associated with aging.
This study is important for demonstrating that the impact of
endometrioma on the follicular reserve is determined by both
the evolution in time and the surgical excision technique. The
data support the recommendation of early-stage ablation of the
endometriotic implant and avoid both delay of surgery as well
as excision technique.
The morphological data on follicle loss in women with
endometrioma has been confirmed by the impact of
endometrioma on serum anti-Mullerian hormone (AMH),
which is proposed as a marker of ovarian reserve. In a retro-
spective study comparing serum AMH levels in 1642 infertil-
ity patients without endometrioma and 141 patients with
endometrioma, Hwu et al. [32] found that both ovarian
endometrioma and cystectomy are associated with a signifi-
cant reduction on ovarian reserve. Moreover, the mean serum
AMH level was significantly lower in patients with bilateral
endometrioma compared to that of patients with unilateral
endometrioma. A lower concentration of AMH in patients
with ovarian endometriomas before any surgery compared to
normal ovaries is also described by Pacchiaroti et al. [33].
Kitajima et al. [34] demonstrated that in ovaries with
endometriomas less than 4 cm in diameter, follicular density
is significantly lower than in cortex from contralateral normal
ovaries. In their 2014 paper [35], a so-called “burnout” hy-
pothesis has been described with an accelerated follicular re-
cruitment and atresia in early follicles found in ovaries with
endometriomas and not in the cortex of contralateral ovaries
without endometriomas. Focal inflammation results in the
structural alteration of the ovarian cortex, with massive fibro-
sis and loss of cortex-specific stroma. Focal loss of follicular
density may be associated with a “vicious circle of dysregu-
lated folliculogenesis that eventually results in a burnout of the
stockpile of dormant follicles.”
Fibrosis of the endometriotic cyst was also frequently ob-
served (9/13) in the study of Schubert et al. [36] while this was
not present in case of dermoid cyst and serous cyst where the
ovarian cortex only seemed to be stretched by the cyst and not
damaged.
Delay in diagnosis
According to the endometriosis literature, the two main rea-
sons why medical advice is sought are chronic pelvic pain and
infertility. However, several studies have shown that the onset
of symptoms precedes by several years the diagnosis of endo-
metriosis. In a study comparing demographic, epidemiologi-
cal, and medical data, Dmowski et al. [37] noted that in the
pelvic pain group, there was a negative correlation between
the age at first symptom and the stage of endometriosis at the
time of first diagnosis. Thus, the longer the diagnosis was
delayed, the more the endometriosis was in an advanced stage
at the time of diagnostic laparoscopy. The frequency of stage
IVendometriosis at the time of initial laparoscopy was signif-
icantly higher in the pelvic pain group than in the infertile
group (31 vs. 12%). This suggests a more expedient diagnosis
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in infertile women as compared with those presenting pelvic
pain symptoms.
The study also found that the majority of women with
endometriosis and infertility had either mild or no pelvic pain
symptoms, suggesting the possibility of asymptomatic endo-
metriosis. According to previous studies, unsuspected endo-
metriosis is found in multiparous women undergoing laparo-
scopic tubal sterilization with a prevalence ranging between 2
[38] and 3.7 % [39]. Hadfield et al. [40] recruited through
endometriosis self-help groups a total of 218 women with
surgically confirmed endometriosis. US women had a mean
±SD delay in diagnosis of 11.73±9.05 years, while in UK
women, the delay of 7.96±7.92 years was significantly lower.
Interestingly, American women reported their symptoms to
commence some 5 years earlier than British women. Husby
et al. [41] reported that the mean delay from the onset of
symptoms to diagnosis included two phases of delay: first, a
delay from the onset to a doctor visit of 1.4±2.9 years, and
secondly, a delay from the doctor visit to establishing a surgi-
cal diagnosis of 5.2±5.6 years. It is noteworthy that 21 (6.4%)
of 328 patients with proven endometriosis were diagnosed
without pain symptoms.When excluding this group, the mean
diagnostic delaywould be 6.5±6.3 years and the median delay
5.0 years. Factors influencing the delay in diagnosis included
the IVF that can be performed without previously performing
laparoscopy and that endometriosis can be present without
pain. According to the study of Arruda et al. [42], the interval
was dependent on the primary symptom since women with
infertility took 4 years to be diagnosed with endometriosis,
whereas 7.4 years elapsed from symptoms to diagnosis in
patients with pelvic pain. A recent multicenter study per-
formed principally in primary care found a delay of 6.7 years
between the onset of symptoms and a surgical diagnosis of
endometriosis [43]. The delay was longer in centers where
women received predominantly state-funded health care (8.3
vs. 5.5 years) and positively associated with the number of
pelvic symptoms (chronic pelvic pain, dysmenorrhea, and
dyspareunia) and heavy periods and a higher body mass in-
dex. However, it has been documented that menstrual symp-
toms, while raising a high degree of suspicion for endometri-
osis, are not reliable as indicators of the severity of disease
[44, 45].
Early-stage management
Early-stage management of endometriosis in the adolescent
involves exclusion of reproductive tract anomaly, monitoring
the response of pelvic pain to medical treatment and the early
ultrasound diagnosis of an endometrioma and, in such cases,
full ablative surgery of the ectopic endometrial tissue. The
combined oral contraceptive pill has been used for the treat-
ment of endometriosis-associated pain, such as dysmenorrhea
for several years. The treatment may also relieve deep
dyspareunia, non-cyclic pelvic pain, and dyschezia. While
adolescent endometriosis is a hidden, progressive, and severe
disease, the medical and surgical tools for diagnosis and treat-
ment should be effective, but minimally invasive.
Psychological benefits of early-stage diagnosis
Two studies have evaluated in detail the benefits of early di-
agnosis for the patient. Ballard et al. [46, 47] investigated the
reasons why women experience delays in the diagnosis of
endometriosis and the impact of this in a qualitative
interview-based study of 32 women, 28 of whom were subse-
quently diagnosed with endometriosis. Delays in the diagnosis
of endometriosis occur at an individual patient level and a
medical level, as both women and family doctors normalize
symptoms, symptoms are suppressed through hormones, and
nondiscriminatory investigations are relied upon. Women
benefited from a diagnosis because it provided a language in
which to discuss their condition, offered possible management
strategies to control symptoms, and provided reassurance that
symptoms were not due to cancer. Diagnosis also sanctioned
women’s access to social support and legitimized absences
from social and work obligations. They concluded that al-
though recent guidelines for the management of chronic pel-
vic pain suggest that diagnostic laparoscopy may be consid-
ered a secondary investigation after the failure of therapeutic
interventions, the present study highlights the importance of
an early diagnosis for women who suffer at physical, emotion-
al, and social levels when they remain undiagnosed.
Nnoaham et al. [43] assessed the impact of endometriosis
on health-related quality of life (HRQoL) and work produc-
tivity in a multicenter cross-sectional study with prospective
recruitment from 16 clinical centers in ten countries. Delay
was positively associatedwith the number of pelvic symptoms
(chronic pelvic pain, dysmenorrhea, dyspareunia, and heavy
periods) and a higher body mass index. They concluded that
endometriosis impairs HRQoL and work productivity across
countries and ethnicities, yet women continue to experience
diagnostic delays in primary care. A higher index of suspicion
is needed to expedite specialist assessment of symptomatic
women. Future research should seek to clarify pain mecha-
nisms in relation to endometriosis severity.
It is clear that supportive and comprehensive treatment
should be provided until the completion of childbearing.
Imaging diagnosis of ovarian endometrioma
Transvaginal ultrasound is the first choice for monitoring the
ovaries for early-stage development of a uni- or bilateral
endometrioma. In the study of Holland et al. [48], the sensi-
tivity and specificity of preoperative ultrasound for the detec-
tion of ovarian endometrioma are, respectively, 84.0 (95 % CI
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73.7–91.4) and 95.6 (95 % CI 92.8–97.6), although the diam-
eter of the endometriotic cyst was not mentioned. In his paper,
Raine-Fenning [49] reported that the results of the predictive
value of 2-D ultrasonographic patterns for the detection of
endometrioma were very discrepant with a variation of sensi-
tivity and sensibility, respectively, ranging from 64–89 to 89–
100 mostly due to inappropriate ultrasonographic diagnosis.
In experienced hands, the technique allows reliably the diag-
nosis of an endometrioma with a size of more than 1–2 cm in
diameter. With the use of B-Mode ultrasound and mean gray
value, Alcazar et al. [50] reported a sensitivity of 80 (58–92)
(95 % CI) and a specificity of 91 (77–97) (95 % CI) with a
LR+ of 9.1 (3.0–27.3) and a LR− of 0.2 (0.1–0.5) (95 % CI).
In most of the studies reporting the sensitivity and specificity
of ultrasound in the differential diagnosis of the pathologic
cysts, the mean diameter of the cyst is seldom mentioned,
neither the relation of the diameter of the cyst and the accuracy
of differential diagnosis. The lowest reported diameter varies
between 18 and 24 mm [51–53]. In our consecutive series of
169 patients where endometriosis was diagnosed at
transvaginal hydrolaparoscopy (THL), routine preoperative
transvaginal ultrasound only detected 45 % of endometriomas
smaller than 15 mm [25].
The place of transvaginal endoscopic surgery
Atraumatic ovarian surgery, to avoid loss of ovarian reserve, is
based on early-stage diagnosis when cystectomy can be
avoided. Although laparoscopy is traditionally recommended,
transvaginal endoscopy has been shown to be safe and most
effective in ablating ovarian endometriomas that are not larger
than 3 cm in diameter [54, 55]. As the transvaginal laparosco-
py is performed using a watery distension medium, it enables
accurate visualization of the vascularization of superficial
implants and adhesions covering the site of small
endometriotic lesions. Apart from the watery distension me-
dium, the supplementary advantage of the transvaginal ap-
proach is that it allows inspection of the tubo-ovarian organs
in their natural position with easy exploration of the fossa
ovarica without the need of manipulating instruments. Brown-
ish vesicles present upon the ovarian surface are by closer
inspection small invaginated hemorrhagic lesions in the ovar-
ian cortex covered by thin adhesions. Adhesions can be ablat-
ed without extra manipulation. The site of invagination can
clearly be identified. By the use of a bipolar needle, the
pseudocystic invagination is opened. At the basis of these
small invaginations, endometrial-like tissue is identified. After
rinsing and identification of the endometrial-like tissue lining
the wall, full ablation is easily performed using a 5-Fr. bipolar
coagulation probe (Fig. 1). As the whole procedure is per-
formed under hydroflotation, no carbonization occurs and
the risk of surgical trauma and adhesion formation is minimal.
By close inspection and in the presence of adhesions with the
posterior leaf, areas of endometrium-like tissue in the lateral
wall can be identified and coagulation is performed. The ab-
sence of an elevated intra-abdominal pressure due to the CO2
pneumoperitoneum at standard laparoscopy enables not only a
better visualization of superficial adhesions and vasculariza-
tion, but the procedure is also performed in the absence of a
status of intra-abdominal hypoxia present at standard laparos-
copy. It is questionable if such a long time exposure to the
hypoxia caused by the CO2 pneumoperitoneum is finally not
detrimental for the ovarian reserve and is a co-factor for the
diminished AMH concentration after surgery.
In young patients with severe dysmenorrhea, we suggest
the following decision tree: In a first step, presence of
rectovaginal endometriosis and/or ovarian endometrioma
should be excluded by a clinical examination and transvaginal
Fig. 1 Ablative surgery of small
ovarian endometrioma by
transvaginal hydrolaparoscopy.
From upper left to right under.
Opening of cyst with
visualization of
microvascularization at the base.
Close-up (under water) of insight
cyst: remark the pertinent vascu-
larization and the presence of en-
dometrial tissue on the right. Use
of bipolar probe for ablative sur-
gery. Final result after ablation:
remark the absence of carboniza-
tion and the white color of the in-
sight comparable with the ovarian
cortex
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ultrasound. In case of negative examination, patient can be put
upon oral contraception and/or NSAID with yearly follow-up;
in case of persistence or aggravation of pain, a transvaginal
hydrolaparoscopy (THL) or in case of contraindication for a
vaginal access standard laparoscopy (SL) should be per-
formed and endometriotic lesions should be treated. In case
of diagnosis of ovarian endometriosis in the absence of
rectovaginal pathology at clinical examination, a six monthly
follow-up under a contraceptive pill is advocated to exclude
the increase of the ovarian endometrioma and to evaluate the
regression of pain. In case of non-regression of the pain and/or
increase of the size of the endometrioma, endoscopic explo-
ration and treatment by THL or SL are mandatory. In the
presence of rectovaginal endometriosis, the necessary explo-
ration must be done before referring patient for an operative
laparoscopic procedure (Fig. 2).
In the absence of contraindications for a vaginal access [55]
and if the size of the endometrioma does not exceed 3 cm, a
THL in our hands is preferable. Deep or adenomyotic lesions
are rare in adolescents, and as long as there is no evidence,
which peritoneal lesions will develop into adenomyotic or
deep lesions, there is in our view no indication for “preven-
tive” standard laparoscopy. At THL, the anterior cul de sac
cannot be visualized. In asymptomatic patients, however, iso-
lated lesions of the bladder are infrequent [56]. In patients with
chronic pelvic pain and DIE, the incidence of bladder endo-
metriosis is reported to be 1.58 % [57] until 6.6 % [58] and
patients were complaining of frequent urination and dysuria. It
is worth asking whether inspection of the anterior pelvis is
necessary in infertility in the absence of tubo-ovarian pathol-
ogy and in the absence of chronic pelvic pain or urinary com-
plaints. In the presence of clinical symptoms suspicious for
bladder endometriosis, appropriate investigation including
MRI and standard laparoscopy is advocated. In Finland, the
annual incidence, as evaluated from The Finnish Care
Register HILMO, increased from 3.6 to 9.4 cases/1,000,000
females aged 15–49 years per year during 1996–1999 and
2004–2007, respectively [59].
Can endometriosis in the adolescent be cured by full ablation?
At present, there is no evidence that in the adolescent all subtle
peritoneal endometriosis can be visualized at laparoscopy. A
variety of subtle lesions have been described [60], but the
main visual criterion is the presence of microvascularization
and cyclic bleeding. For this reason, GnRH agonist can cause
disappearance of lesions, but they recur once the treatment is
stopped and menstruations follow [61]. A major problem is
that, at laparoscopy, the pneumoperitoneum causes collapse of
the capillary blood flow inside and surrounding the implants,
masking to a large extent the microvascularization in and to-
wards the active subtle lesion. The recent study byYeung et al.
[62] suggested that complete laparoscopic excision of all areas
of abnormal peritoneum with typical and atypical endometri-
osis has the potential to eradicate disease. This publication,
however, was criticized by Laufer and Missmer [63] for the
statement that the lack of visible endometriosis at second look
laparoscopy in a relatively small number of patients was proof
of the eradication of disease. As far as peritoneal endometri-
osis is concerned, the appearance may be variable and hor-
monal treatment may mask implants. Scanning electron mi-
croscopy can show the presence of invisible lesions in women
with infertility and endometriosis [64]. Therefore, in the ab-
sence of the evidence that ablations of peritoneal endometri-
osis can cure the disease, the main issue is the full preservation
of the ovarian function during reproductive life.
Discussion
From the early onset of female neonatal life, due to neonatal
bleeding and retrograde menstruation, endometrial cells in-
vade the pelvis and are possibly at the origin of the presence
of premenarchal and adolescent endometriosis.
It is hard to understand why the diagnosis of endometriosis
is so long delayed resulting in severe stages of endometriosis
including a frozen pelvis. As health practitioners, we have to
question ourselves why we are missing the development of
this disease in individual women. Not only the patient herself
is unaware of objective symptoms like severe dysmenorrhea
and superfluous or frequent menstruation resulting in a late
medical advice but also the general practitioners or gynecolo-
gist is not sufficiently sensitized for the importance of the
symptoms. Furthermore, diagnosis is impaired as there is not
a good correlation between the severity of the disease and the
symptoms. All these results are a delay of an accurate diagno-
sis between the onset of symptoms and the final diagnosis.
TV-US / clinical examination 
  Normal 
Hormonal medication 
NSAID 
Effective Not effective 







Fig. 2 Decision tree in young patients with severe dysmenorrhea. The
necessary exploration must be done before referring patient for an
operative laparoscopic procedure
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Certainly, in adolescents with chronic pelvic pain such as dys-
menorrhea resistant to medication, the incidence of endome-
triosis is around 70 % [7]. Early ultrasound diagnosis and
meticulous follow-up are mandatory. Whether full ablative
surgery should be envisaged in an early stage of the disease
causing a minimal damage to the ovarian reserve is still de-
batable and requires further investigation. Long-standing pres-
ence of ovarian endometriotic cysts results in SMM and fibro-
sis of the ovarian cortex, impairing the ovarian reserve. Deci-
sions to operate should be carefully balanced against the
growing concern of potential damage of surgery upon the
ovarian reserve [65, 66]. It is however questionable if the size
of the ovarian endometrioma is of any importance in this de-
cision process. The suggested diameter of 3 cm in the ESHRE
guidelines is pure arbitrarily and not based upon any scientific
evidence [67]. Alborzi et al. [65] demonstrated that the size of
the cyst is inversely proportional with the ovarian reserve. The
detrimental effect of the ovarian endometrioma on the follicle
concentration and fibrosis, as described in the study of
Kitajima et al. [34], was in ovarian endometrioma with a di-
ameter smaller than 4 cm.
The purpose of an early intervention is the treatment of
pain, prevention of the progression, and protection of the fer-
tility [68]. As endometriosis is assumed to be a progressive
disease, the ACOG recommends the early diagnosis and treat-
ment in the adolescent [69]. In the editorial of Evers [70]
evaluating the natural course of the disease in adults, the dis-
ease progressed in 29 %, while in the rest of the patients, the
disease regressed or stayed stable. The issue of no progression
and even disappearance involved mostly peritoneal endome-
triosis stages I and II, but not ovarian endometriosis [71]. In a
prospective cohort study, Alcazar et al. [72] reported a spon-
taneous disappearance of endometriotic cysts in 30 % of the
endometrioma diagnosed by ultrasound. In his study group,
however, the mean age of the patients was 40.2±8.5 years and
33.7 % of the patients became menopausal during the follow-
up period [mean follow-up time 45 months (9–109 months)].
It remains questionable first if these findings can be extrapo-
lated to the adolescents, where the disease is more aggressive
and, secondly, if no visualization at ultrasound means com-
plete resolution of the disease as SMM and fibrosis can go on.
In adolescents, the diagnosis is frequently postponed until
several years after the onset of symptoms [37, 41, 42]. It is
true that, at this moment, the progressivity of the disease can-
not be predicted, but the frequent observation of severe stages
of endometriosis, even in the absence of pain, is an indication
of the progressivity of the disease in the adolescents and de-
serves our full attention. In a retrospective analysis of postop-
erative evolution of endometriosis in adolescents, Yang et al.
[9] described a recurrence in 53 % of the adolescents, only in
the small group of five patients receiving GnRha postopera-
tively in which no recurrence was observed. Amore beneficial
effect of acupuncture and Chinese medication in the
prevention of recurrence of endometriosis is mentioned in
the study of Zhang et al. [73] compared to the use of
gestrinone. A higher recurrence rate of endometriosis of
56 % in young women has been mentioned by Tandoi et al.
[74], illustrating the degree of aggressiveness of the disease in
adolescents.
As ablative surgery of small endometrioma intends to be
more accurate and complete, reasonably, we could expect, al-
though not proven, that this will result in a lower recurrence
rate, being easier to perform and minimal invasive. Pados et al.
[75] and Donnez et al. [76] advice to perform surgery for ovar-
ian endometrioma larger than 5 cm in a two-step procedure
enabling more accurate surgery on a smaller cyst in the second
time and minimizing the risk of damaging the ovarian reserve.
The use of the transvaginal endoscopic approach adds to
the minimally invasiveness of the procedure. The use of a
watery distension medium allows an accurate visualization
and early detection. Ablative surgery is done using a micro
5 fr bipolar probe causing minimal damage. In the absence of
a panoramic view, the transvaginal endoscopic procedure is
limited to the treatment of small endometrioma (<3 cm).
Endometriotic cysts differ from other benign cysts as they
are extra-ovarian pseudocysts with the absence of a clear de-
lineated capsule and not restricting the disease to the cyst itself
but affecting the surrounding cortex by SMM and fibrosis.
This explains the difference in ovarian reserve between pa-
tients with a dermoid cyst and an endometriotic cyst, with a
negative impact on the latter.
Conclusion
Early diagnosis of endometriosis in the adolescent deserves our
full attention. Early ablative surgery can contribute to a lower
morbidity, a relief of symptoms, and a better quality of life.
Treatment in early stage will result in less damage to the ovary
caused by the disease itself and by a less invasive surgical pro-
cedure. Endometrial cells on the surface of the ovary carry the
risk to affect the ovary in two ways: first by causing ovarian
adhesions and pseudocysts and secondly by causing mesenchy-
mal cell metaplasia in the interstitial ovarian tissue, sclerosis, and
follicle loss. Similar as in oncology, there is no reason to wait.
Further research has to be done to elucidate if such early
treatment will result in lower recurrence rates and less severe
forms of the disease.
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